News Detail
New Delhi, 6 Nov 2024: Roche, a Swiss multinational healthcare company, is seeking a permanent injunction against Natco Pharma to prevent the introduction of a generic version of Risdiplam, a Spinal Muscular Atrophy (SMA) drug, citing patent infringement.
H......
View Details
Source : The Telegraph India
Roche
spinal muscular atrophy
Natco Pharma
patent
generic drug
Delhi High Court
Related News
- Indian pharma and IT sectors will be in focus amid Trump's big election win (06-11-2024)
- Three crore psychotropic Tablets made in eight months (06-11-2024)
- Govt should arrange QR code for the quality of medicines: Himachal HC orders (06-11-2024)
- Typhoid treatment: Study detects antibiotic resistance (06-11-2024)
- WHO study lists top endemic pathogens for which new vaccines are urgently needed (06-11-2024)
- DCGI frames rules for safety, quality of imported cosmetics (06-11-2024)
- ADC caught by Lokayukta taking bribe in Bengaluru (06-11-2024)
- Expired medicines worth Rs 6 lakh seized in Meerut (05-11-2024)
- 738 drug samples failed in the state in five years, action taken against six percent only (05-11-2024)
- Stent not Removed After PCNL: Hospital, surgeon Slapped Rs 35 Lakh Compensation for Deficiency in Service (05-11-2024)